All research
Tirzepatide 2026-07-28 PubMed

Overcoming Gastric Barriers for Oral Peptide Delivery: QbD-Based Development of Sodium Caprate-Enabled Tirzepatide Tablets.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


tirzepatide oral delivery sodium caprate qbd peptide formulation type 2 diabetes
Source: pubmed:42514904 · Ingested Jul 28, 2026